Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is The Hydration Pharmaceuticals Co EV-to-EBIT?
The Hydration Pharmaceuticals CoASX:HPC EV-to-EBIT is -1.41 as of Jul. 16, 2026. The stock has 3 warning signs investors should review. Among 261 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 383141.38% on this metric.
The Hydration Pharmaceuticals Co (ASX:HPC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
The Hydration Pharmaceuticals Co's Enterprise Value for the quarter that ended in Dec. 2025 was A$0.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co EV-to-EBIT Related Terms
The Hydration Pharmaceuticals Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co EV-to-EBIT vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's EV-to-EBIT falls into.
The Hydration Pharmaceuticals Co's current Enterprise Value is A$5.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co (ASX:HPC) has a EV-to-EBIT of -1.41 as of Jul. 16, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #999999 out of 261 companies in the Retail - Defensive industry.
Is The Hydration Pharmaceuticals Co's EV-to-EBIT too high?
The Hydration Pharmaceuticals Co's current EV-to-EBIT is -1.41. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #999999 out of 261 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's EV-to-EBIT compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #999999 out of 261 companies for EV-to-EBIT. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median EV-to-EBIT is 13.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Retail - Defensive company?
The median EV-to-EBIT among Retail - Defensive companies is 13.40, based on 261 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median EV-to-EBIT is 13.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current EV-to-EBIT is -1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current EV-to-EBIT of -1.41. The current EV-to-EBIT is -1.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current EV-to-EBIT is -1.41 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 
